Skip to main content

Published locations for Psoriasis, Biologics: Concern Remains About CV Risks

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Psoriasis, Biologics: Concern Remains About CV Risks

User login

  • Reset your password
  • /content/psoriasis-biologics-concern-remains-about-cv-risks
  • /edermatologynews/article/37141/cardiology/psoriasis-biologics-concern-remains-about-cv-risks
  • /familypracticenews/article/37141/cardiology/psoriasis-biologics-concern-remains-about-cv-risks
  • /internalmedicinenews/article/37141/cardiology/psoriasis-biologics-concern-remains-about-cv-risks
  • /internalmedicine/article/37141/cardiology/psoriasis-biologics-concern-remains-about-cv-risks
  • /dermatology/article/37141/cardiology/psoriasis-biologics-concern-remains-about-cv-risks
  • /familymedicine/article/37141/cardiology/psoriasis-biologics-concern-remains-about-cv-risks
  • /dermatology/psoriasiscollection/article/37141/cardiology/psoriasis-biologics-concern-remains-about